Effect of Continuous Kidney Replacement Therapy (CRKT) on Thyroid Function

Background: Thyroxine (T4) and triiodothyronine (T3) are low molecular weight proteins (0.78 and 0.65kDa, respectively) amenable to removal by CKRT. Herein, we quantified T3/T4 clearance during CKRT and tested the hypothesis that CKRT would affect the hypothalamic-pituitary-thyroid (HPT) axis and cause a rise in serum thyroid stimulating hormone (TSH). Methods: In 24 patients undergoing continuous veno-venous hemodialysis, we measured CKRT effluent and serum levels of TSH, free T4 (FT4), free T3 (FT3), and reverse T3 (rT3) on Days 1, 3, 8 and 14 of CKRT. Baseline TSH and FT4 was measured <12 hours prior to CKRT initiation. In all cases, fresh samples were measured in the clinical lab. On each day of CKRT, sieving coefficient (SCx=[x]effluent/[x]serum), clearance (liters cleared=SCx*total effluent volume in prior 24 hours), and Sequential Organ Failure Assessment (SOFA) scores were calculated. Thyroid function tests were interpreted by an endocrinologist using prespecified definitions of euthyroid sick syndrome (ESS) and hypothyroidism. Results: Mean SC of TSH, FT4, and FT3 was 0.15 (n=48), 0.27 (n=46), and 1.04 (n=49), respectively and did not change between days on CKRT. SOFA scores were similar on each day. Serum TSH was higher on D8 vs. D3, D8 vs. D1, D8 vs. Pre-CKRT and D3 vs. D1 (Figure 1A). Serum T4 decreased on D3 and D1 of CKRT, relative to pre-CRKT (Figure 1B). TSH, FT4, and FT3 clearance is shown in Figure 1E-F. One patient met criteria for hypothyroidism, with the remaining patients in various stages of ESS. Conclusion: T3 and T4 removal occurs during CKRT. To our knowledge this is the first report to quantify T3 and T4 removal during CKRT and the first to describe the development of hypothyroidism after CKRT initiation (n=1). Even in patients with ESS (n=23), a physiologic effect of T3 and T4 removal on the HPT axis is suggested by the significant rise in TSH. These data suggest that hypothyroidism is a novel complication of CKRT.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2024-10-01
DOI
https://doi.org/10.1681/asn.2024aa9arcgp
Primary Topic
Folate and B Vitamins Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of Continuous Kidney Replacement Therapy (CRKT) on Thyroid Function

Sarah M. Haeger, North Foulon, Warren H. Capell, David S. Madison et al.
Journal of the American Society of Nephrology
Folate and B Vitamins Research
article

Effect of Continuous Kidney Replacement Therapy (CRKT) on Thyroid Function

Sarah M. Haeger, North Foulon, Warren H. Capell, David S. Madison, Mitzy Kennis, Sarah Faubel, Isadore M. Budnick, Kayo Okamura, Zhibin He
article en

Abstract

Background: Thyroxine (T4) and triiodothyronine (T3) are low molecular weight proteins (0.78 and 0.65kDa, respectively) amenable to removal by CKRT. Herein, we quantified T3/T4 clearance during CKRT and tested the hypothesis that CKRT would affect the hypothalamic-pituitary-thyroid (HPT) axis and cause a rise in serum thyroid stimulating hormone (TSH). Methods: In 24 patients undergoing continuous veno-venous hemodialysis, we measured CKRT effluent and serum levels of TSH, free T4 (FT4), free T3 (FT3), and reverse T3 (rT3) on Days 1, 3, 8 and 14 of CKRT. Baseline TSH and FT4 was measured <12 hours prior to CKRT initiation. In all cases, fresh samples were measured in the clinical lab. On each day of CKRT, sieving coefficient (SCx=[x]effluent/[x]serum), clearance (liters cleared=SCx*total effluent volume in prior 24 hours), and Sequential Organ Failure Assessment (SOFA) scores were calculated. Thyroid function tests were interpreted by an endocrinologist using prespecified definitions of euthyroid sick syndrome (ESS) and hypothyroidism. Results: Mean SC of TSH, FT4, and FT3 was 0.15 (n=48), 0.27 (n=46), and 1.04 (n=49), respectively and did not change between days on CKRT. SOFA scores were similar on each day. Serum TSH was higher on D8 vs. D3, D8 vs. D1, D8 vs. Pre-CKRT and D3 vs. D1 (Figure 1A). Serum T4 decreased on D3 and D1 of CKRT, relative to pre-CRKT (Figure 1B). TSH, FT4, and FT3 clearance is shown in Figure 1E-F. One patient met criteria for hypothyroidism, with the remaining patients in various stages of ESS. Conclusion: T3 and T4 removal occurs during CKRT. To our knowledge this is the first report to quantify T3 and T4 removal during CKRT and the first to describe the development of hypothyroidism after CKRT initiation (n=1). Even in patients with ESS (n=23), a physiologic effect of T3 and T4 removal on the HPT axis is suggested by the significant rise in TSH. These data suggest that hypothyroidism is a novel complication of CKRT.

Journal of the American Society of NephrologyVol. 35(10S)
University of Colorado Anschutz Medical Campus (US)
Good health and well-being
Openalex Percentile: Top 67%
Folate and B Vitamins Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.